Novartis digital onboarding experience for RMS patients learning self-injection nominated for UX Design Award

07 Jul 2026 3min read

Novartis has been nominated for a UX Design Award for a new drug delivery digital onboarding experience, developed in collaboration with Team Consulting. Designed to support patients with relapsing forms of multiple sclerosis (RMS) in learning to self-inject, the digital platform has been nominated in recognition of its user-centred design to help patients manage their treatment safely and confidently at home.

The UX Design Awards recognise solutions that improve people’s lives through effective design. Run by the International Design Center Berlin (IDZ), it celebrates products and services that respond to user needs and support better outcomes across healthcare and beyond.

Patient centricity means more than developing great medicines. It is about empowering people to use them safely and confidently in their daily lives.
Nicholas Stones, Director, Human Factors and User Experience, Novartis

A digital platform to support RMS patients learning to self-inject

The Novartis digital platform addresses a significant challenge in self-administration. Many RMS patients use autoinjector pens at home in their treatment, but can face inconsistent onboarding, limited training opportunities and injection anxiety. This can create uncertainty about important steps and techniques, leading to reduced confidence and use errors.

Novartis worked with Team to develop a digital onboarding experience to help tackle this challenge and help patients inject safely and confidently at home. Easily accessible via a QR code on the product packaging, the mobile-optimised, web-based platform provides a range of learning materials tailored to different needs, including:

Clear and navigable written guidance
Animated instructional videos
An interactive, AR-like virtual practice that allows patients to simulate an injection in a low-stress environment.

Supporting RMS patients outside the clinic

The digital onboarding experience complements nurse-led training and the existing approved instructions for use (IFU) provided with the autoinjector, helping to overcome known challenges and use errors associated with learning to self-inject, such as lifting the device too early before the injection is complete.

Alongside improving the patient experience and supporting better health outcomes, the digital approach can reduce reliance on repeated in-person training, helping to ease pressure on healthcare systems.

We wanted to give people a better treatment experience, giving them the information they need from the start in an accessible and interactive way. It’s really exciting to see the importance of the overall user experience being recognised with this nomination.
Lara Zaki, Senior FEI Strategy and Innovation Consultant, Team Consulting

This UX Design Award nomination recognises the value of combining human factors expertise and behavioural science in digital design, and the importance of collaboration to deliver a solution that improves the experience of patients with RMS.

It also emphasises the importance of well-designed onboarding experiences to support safe and effective use of drug delivery devices from the very first injection.

Winners of the UX Design Award will be announced in September. Get in touch to learn more about how Team Consulting supports clients with digital tools that encourage adoption, drive positive behaviours and improve patient outcomes.